Work

Safety and Clinical characteristics of patients with Ovarian cancer: Rucaparib Real-world Evidence (The SCORE Study)

Year: 2025

Type: article

Abstract: Safety and Clinical characteristics of patients with Ovarian cancer: Rucaparib Real-world Evidence (The SCORE Study) - OCC- Print ISSN No: - Online ISSN No:- 3048-6289 Article DOI No:- 10.18231/j.occ.2025.002, Onco Critical Care-Onco Crit Care

Source: Onco Critical Care.

DOI: 10.18231/j.occ.2025.002

Authors: Gajanan Panchal, Atul Narayankar, Rajat Bajaj, Rajesh Kota, Somnath Roy, Vijay Bhargav, Vijay Sharnangat, Vinu Sarathy, Kamlesh Patel, Gurunath Chavan, Chanchal Goswami, Amit Pandey

Institutions: Lupin Pharmaceuticals (India), Wockhardt Hospitals, Fortis Hospital, Tata Medical Center, Jawaharlal Nehru Cancer Hospital and Research Centre, Bangalore Baptist Hospital, AMRI Hospitals

Language: English

Topic: PARP inhibition in cancer therapy

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: hybrid

OpenAlex ID: W4410418554

FWCI:

Cites:

Cited by:

Related to: 10